Amryt Pharma Share Chat (AMYT)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Amryt Pharma Plc	LSE:AMYT	London	Ordinary Share	GB00BKLTQ412	ORD 6P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-1.50	-1.25%	118.50	117.00	120.00	120.00	118.50	120.00	32,845	10:40:01

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	13.0	-23.1	-8.4	-	257

Amryt Pharma Share Discussion Threads

Showing 5251 to 5273 of 5275 messages

Chat Pages: 211 210 209 208 207 206 205 204 203 202 201 200 Older

Date	Subject	Author	Discuss
15/11/2019 19:33	"Cheers & have a splendiforous weekend!!" And let me wish the same for you, bazworth. I could do with an over £20k profit on my modest AMYT investment. Bring it on and the sooner the better! Will it happen? I can't predict share prices, but fingers crossed it does!	papillon	Read Full Thread Reply
15/11/2019 18:48	My eyes are firmly closed! Please text a voice message to me when we get there. My meagre stipend in retirement could do with a good shove!! Cheers & have a splendiforous weekend!!	bazworth	Read Full Thread Reply
15/11/2019 18:34	Another two 25k trades, bazworth, both @ 118p reported after the market closed at 4:35pm. Probably reporting delayed by an hour since there was no after close auction announced. The 118p price dictates they were both sells, but they could have been a rollover because the time difference between the two trades was just 13 seconds. Whatever they were that brings the number of trades today to 22. "Just wait till we’re @ £5 a share!!" When will that be, bazworth? Next week, next month, next year? Have another look into your crystal ball, bazworth, as I need more clarity! Hopefully I don't have to wait too long for that £5 per share as I'm getting on a bit! :-)	papillon	Read Full Thread Reply
15/11/2019 17:23	Marvellous!!! Just wait till we’re @ £5 a share!!	bazworth	Read Full Thread Reply
15/11/2019 16:49	I spoke too soon this morning! Some big volume trades this afternoon. 4 large trades totalling around 112k of shares. The biggest was for 35,650 @ 119.25p. It's shown as a sell because it's reporting was delayed by an hour. However when the trade took place (14:38:20) the quoted spread was 117p - 120p so it was a buy.	papillon	Read Full Thread Reply
14/11/2019 21:44	It's a technicality - when considering valuation just include these shares as still being in issue. They will be reissued for no money when it suits the funds - who can't hold the shares now without breaching limits. Hence no price for the buy back.	bageo	Read Full Thread Reply
14/11/2019 17:15	Share buyback? I don't understand,I don't see any price. https://uk.advfn.com/stock-market/london/amryt-pharma-AMYT/share-news/Amryt-Pharma-PLC-Share-Buyback/81147847	chica1	Read Full Thread Reply
13/11/2019 16:01	O/T. Big drop in the ECO share price today following the RNS. Glad I no longer dabble in speculative AIM O&G's. I'm just gambling on an AIM listed speculative biotech, AMYT, instead!	papillon	Read Full Thread Reply
11/11/2019 21:56	Two massive trades timed at just before 1pm, but only reported after the market closed. Both sells, but the share price responded by going up! I wonder if the trades have been worked over a number of days and have been depressing the share price and that now they have gone the share price will start to rise? These are the two trades: 400,000 @ 115.625p and timed @ 12:55:07. Proceeds £462,500,000 474,135 @ 115.50p and timed @ 12:54:15. Proceeds £547,630,000	papillon	Read Full Thread Reply
10/11/2019 18:03	hTTps://www.thetimes.co.uk/article/agenda-mystery-rises-as-bank-of-china-goes-for-irish-broker-goodbody-cttf2090r Wiley in the right with Amryt Perhaps you should have paid attention in biology class. Joe Wiley, chief executive, and Rory Nealon, chief financial officer, were last week granted options over 10.2m shares in Amryt Pharma, an Irish drug developer. The bumper share awards have an exercise price of £1.215p each. Amryt is an orphan drug specialist, finding treatments for rare diseases. The company recently acquired Aegerion, a Canadian peer and has a drug in development to treat the skin disease epidermolysis bullosa. There are no sure things in pharma, yet Wiley has a top reputation and a nose for a deal. The rewards here could be truly massive. Wiley by name, wily by nature. brian.carey@sunday-times.ie	papillon	Read Full Thread Reply
10/11/2019 17:19	Yep Sunday Times	alphabravo321	Read Full Thread Reply
10/11/2019 13:07	alphabravo321, you posted the following on the lse bb today. Does ST refer to the Sunday Times? tia alphabravo321 Posts: 33 Price: 121.00 No Opinion ST Today 05:30 Wiley in the right with Amryt Perhaps you should have paid attention in biology class. Joe Wiley, chief executive, and Rory Nealon, chief financial officer, were last week granted options over 10.2m shares in Amryt Pharma, an Irish drug developer. The bumper share awards have an exercise price of £1.215p each. Amryt is an orphan drug specialist, finding treatments for rare diseases. The company recently acquired Aegerion, a Canadian peer and has a drug in development to treat the skin disease epidermolysis bullosa. There are no sure things in pharma, yet Wiley has a top reputation and a nose for a deal. The rewards here could be truly massive. Wiley by name, wily by nature.	papillon	Read Full Thread Reply
06/11/2019 13:07	LOL, purple11. Don't forget to wake me up! "So wake me up when it's all over When I'm wiser and I'm older"	papillon	Read Full Thread Reply
06/11/2019 11:31	nite pappy	purple11	Read Full Thread Reply
06/11/2019 11:30	Back to sleep, until the next RNS.	papillon	Read Full Thread Reply
05/11/2019 22:37	https://www.irishtimes.com/business/health-pharma/dublin-pharma-company-amryt-grows-sales-almost-20-1.4072998?mode=amp	tiananmen	Read Full Thread Reply
05/11/2019 19:56	"It looks undervalued at less than 2 x full year sales. Cash helps but will get spent." Don't forget AMYT has debt, waterloo. The amount of debt must also be acknowledged in any attempt at valuing AMYT. Don't forget we've already had a broker note, waterloo. Stiffel's valuation dated 1st October. That was first posted by Bronxville on the lse bb and copied by me onto this bb last week (post 5087). Stiffel reckon … … … "that revenue-generative orphan drug companies trade at 8.8-times historic earnings." Seems rather fanciful to me, but even 4 x historic earnings valuation gives a 240p AMYT share price	papillon	Read Full Thread Reply
05/11/2019 19:24	£zillions........! Sorry, don’t have the expertise - guess that makes me a gambler and not an investor! At least I’m a very patient gambler.... Fingers very firmly crossed!	bazworth	Read Full Thread Reply
05/11/2019 18:55	Well at least they are not free options but have a strike price of £1.21. Makes them as keen as shareholders to see the share price climb. Would love to see a broker note. Any around? It looks undervalued at less than 2 x full year sales. Cash helps but will get spent. Hopefully the combined entity has a reasonable cost base. Any thoughts on appropriate valuation based on revenue now it's more visible?	waterloo01	Read Full Thread Reply
05/11/2019 18:48	Hope it’s positive!	bazworth	Read Full Thread Reply
05/11/2019 18:39	Timing of the options grant is telling in my opinion	alphabravo321	Read Full Thread Reply
05/11/2019 18:23	Big options grant for the lads	alphabravo321	Read Full Thread Reply
05/11/2019 17:17	Big buy just after 4pm. 106,352 @ 122.50p. Cost £130.28k.	papillon	Read Full Thread Reply

Chat Pages: 211 210 209 208 207 206 205 204 203 202 201 200 Older

Your Recent History

LSE

AMYT

Amryt Phar..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.